Raleigh Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Sell |
2,760
-29,698
| -91% | -$1.37M | 0.05% | 224 |
|
|
2025
Q1 | $1.98M | Sell |
32,458
-6,981
| -18% | -$426K | 0.9% | 27 |
|
|
2024
Q4 | $2.23M | Sell |
39,439
-3,041
| -7% | -$172K | 0.86% | 24 |
|
|
2024
Q3 | $2.2M | Buy |
42,480
+12,705
| +43% | +$657K | 0.85% | 19 |
|
|
2024
Q2 | $1.24M | Buy |
29,775
+3,426
| +13% | +$142K | 0.53% | 58 |
|
|
2024
Q1 | $1.43M | Buy |
26,349
+22,383
| +564% | +$1.21M | 0.62% | 52 |
|
|
2023
Q4 | $203K | Buy |
3,966
+2,580
| +186% | +$132K | 0.09% | 185 |
|
|
2023
Q3 | $80.5K | Sell |
1,386
-10,646
| -88% | -$618K | 0.04% | 218 |
|
|
2023
Q2 | $769K | Buy |
12,032
+110
| +0.9% | +$7.04K | 0.38% | 82 |
|
|
2023
Q1 | $826K | Buy |
11,922
+1,541
| +15% | +$107K | 0.41% | 78 |
|
|
2022
Q4 | $747K | Sell |
10,381
-9,231
| -47% | -$664K | 0.39% | 78 |
|
|
2022
Q3 | $1.39M | Sell |
19,612
-1,954
| -9% | -$139K | 0.82% | 38 |
|
|
2022
Q2 | $1.66M | Sell |
21,566
-415
| -2% | -$31.9K | 0.94% | 30 |
|
|
2022
Q1 | $1.61M | Buy |
21,981
+21,862
| +18,371% | +$1.6M | 0.87% | 32 |
|
|
2021
Q4 | $7K | Buy |
+119
| New | +$7K | 0.01% | 213 |
|